SUDEEP PHARMA LIMITED (SUDEEPPHRM)

NSE: ₹758.60
BSE: ₹757.15
Stock Performance
Corporate Announcements
No recent announcements available.

Quarterly Financials

Consolidated Standalone
Particulars Sep 2025 Dec 2025 Mar 2026
Revenue from Operations 162.67 172.34 182.34
YOY Revenue Growth % - - -
Other Income 10.17 6.84 6.42
Total Income 172.83 179.17 188.76
Total Expenses + 113.30 117.40 126.07
Cost of Materials Consumed 70.48 70.26 71.14
Employee Benefit Expense 14.10 15.04 10.52
Other Expenses 32.17 37.13 45.37
Operating Profit 49.37 54.94 56.27
OPM % 30.3% 31.9% 30.9%
Profit Before Tax + 59.53 61.78 62.69
Tax Expense 12.76 14.08 14.15
Tax % 21.4% 22.8% 22.6%
Profit After Tax 46.78 47.70 48.54
EPS (Basic) 4.20 4.29 4.38

Yearly Financial Results

Consolidated Standalone
Particulars Mar 2026
Revenue from Operations 642.26
YOY Revenue Growth % -
Other Income 28.59
Total Income 670.84
Total Expenses + 442.77
Cost of Materials Consumed 269.50
Employee Benefit Expense 51.89
Other Expenses 141.16
Operating Profit 199.49
OPM % 31.1%
Profit Before Exceptional 228.07
Exceptional Items 0.00
Profit Before Tax + 228.07
Tax Expense 53.79
Tax % 23.6%
Profit After Tax 174.28
EPS (Basic) 15.50

Balance Sheet

Particulars Mar 2026
ASSETS
Non-Current Assets + 550.91
Property, Plant & Equipment 224.00
Capital Work in Progress 178.43
Non-Current Investments 0.00
Goodwill 68.24
Other Intangible Assets 0.19
Current Assets + 623.97
Inventories 216.05
Trade Receivables 227.54
Cash and Cash Equivalents 26.74
Current Investments 0.00
LIABILITIES & EQUITY
Total Equity 898.09
Equity Share Capital 11.29
Other Equity 872.04
Non-Current Liabilities 74.82
Current Liabilities 201.96
Total Liabilities 276.78

Cash Flow Statement

Particulars Mar 2026
Cash from Operating Activities 69.55
Cash from Investing Activities -327.19
Cash from Financing Activities 247.29
Net Increase/Decrease in Cash -10.07